Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication January 23, 2019
- Accepted for publication March 4, 2019
- Published online October 1, 2019.
Article Versions
- previous version (March 8, 2019 - 13:06).
- previous version (August 12, 2019 - 06:13).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Burcak Yilmaz1,
- Serap Nisli1,
- Nurhan Ergul1,
- Riza Umar Gursu2,
- Ozgur Acikgoz3 and
- Tevfik Fikret Çermik1
- 1Nuclear Medicine Department, Istanbul Research and Training Hospital, University of Health Sciences, Istanbul, Turkey
- 2Medical Oncology Department, Istanbul Research and Training Hospital, University of Health Sciences, Istanbul, Turkey; and
- 3Medical Oncology Department, Kanuni Sultan Suleyman Research and Training Hospital, University of Health Sciences, Istanbul, Turkey
- For correspondence or reprints contact: Burcak Yilmaz, University of Health Sciences, Kasap İlyas Mah., Org. Abdurrahman Nafiz Gürman Cd., Fatih, Istanbul 34098, Turkey. E-mail:drburcak{at}gmail.com
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- 177Lu-PSMA Therapy
- Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)
- The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study